Imaging tools like X-rays and MRI have revolutionized medicine by giving doctors a close up view of the brain and other vital organs in living, breathing people. Now, Columbia University researchers report a new way to zoom in at the tiniest scales to track changes within individual cells.
You are here
Tumor Comments (0)
cientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumor in real time, revealing which cells interact with the drug and which cells the drug fails to reach.
In the future, the findings, published in Nature Communications, could help clinicians decide the best course and delivery of treatment for cancer patients.
Researchers have used open source data to develop a personalized risk assessment tool that can predict survival rate and treatment outcomes among patients with early-stage lung cancer.
The tool uses a panel of 29 extracellular matrix (ECM) genes that the researchers found were abnormally expressed in lung tumor tissue.
The traditional way of targeting cancer has been a “one size fits all” approach, but although two people may have the same type of cancer, the disease can still manifest and progress in a way that is unique to each individual.